Capital International Investors G1 Therapeutics, Inc. Transaction History

Capital International Investors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$14.4 - $21.45 $1.94 Million - $2.9 Million	-135,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $2.15 Million - $6.67 Million	-130,000 Reduced 49.06%	135,000 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$43.15 - $67.97 $11.4 Million - $18 Million	265,000 New	265,000 $13.9 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.